XML 31 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
10. Share-Based Employee Compensation
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
10. Share-Based Employee Compensation

The Company has an employee and non-employee director incentive compensation equity plan. Related to these programs, the Company recorded $95 and $55 of share-based employee compensation expense during the years ended December 31, 2018 and 2017, respectively, which is included as a component of cost of products and SG&A expenses in the accompanying consolidated statements of operations. No amount of share-based employee compensation expense was capitalized as part of capital expenditures or inventory for the years presented.

 

The Company uses the Black-Scholes-Merton option valuation model to calculate the fair value of a stock option grant. The share-based employee compensation expense recorded in the years ended December 31, 2018 and 2017 was calculated using the assumptions noted in the following table. Expected volatilities are based on the historical volatility of the Company’s common stock over the period of time, commensurate with the expected life of the stock options. The dividend yield assumption is based on the Company’s expectations of dividend payouts at the grant date. In 2018, the Company paid dividends on January 16, for a dividend declared in 2017, April 16, July 16 and October 15. In 2018, the Company’s Board of Directors also declared a quarterly dividend that was paid on January 16, 2019. The Company has estimated its future stock option exercises. The expected term of option grants is based upon the observed and expected time to the date of post vesting exercises and forfeitures of options by the Company’s employees. The risk-free interest rate is derived from the average U.S. Treasury rate for the period, which approximates the rate at the time of the stock option grant.

 

    FY 2018     FY 2017  
Expected Volatility     51.9 %     53.6 %
Expected Dividends     2.0 %     5.0 %
Expected Term (in years)     6.5     3.0-6.5
Risk-Free Rate     2.76 %     2.10 %
Estimated Forfeitures     0.0 %     0.0 %

 

A summary of stock option activity under the Company’s equity compensation plans as of December 31, 2018, and changes during the year ended December 31, 2018, are presented below:

 

    Stock    

Wgt. Avg.

Exercise

Price ($)

   

Wgt. Avg.

Remaining

Contractual

   

Wgt Avg.

Grant Date

Fair Value ($)

   

Aggregate

Intrinsic

 
As of January 1, 2018   Options     Per Share     Life (Years)     Per Share     Value ($)  
Outstanding     354,500       4.46             1.79        
Vested     113,000       3.75             2.23        
Nonvested     241,500       4.80             1.58        
                                         
Period activity                                        
Issued     130,000       3.72             1.62        
Exercised                              
Forfeited     24,000       5.10             1.37        
Expired                              
                                         
As of December 31, 2018                                        
Outstanding     460,500       4.22       7.08       1.76       43,860  
Vested     156,900       4.03       3.87       2.05       39,860  
Nonvested     303,600       4.32       8.73       1.61       4,000  

 

Outstanding:

 

Range of Exercise Prices

($) Per Share

   

Stock Options

Outstanding

   

Wgt. Avg. Exercise

Price ($)

Per Share

   

Wgt. Avg. Remaining Contractual

Life (Years)

 
  1.89-3.75       156,000       3.47       8.41  
  3.83-5.10       304,500       4.60       6.39  
          460,500       4.22       7.08  

 

Exercisable:

 

 

Range of Exercise Prices

($) Per Share

   

Stock Options

Exercisable

   

Wgt. Avg. Exercise

Price ($) Per Share

 
                     
  1.89-3.75       26,000       2.22  
  3.83-5.10       130,900       4.39  
          156,900       4.03  

 

The weighted-average grant-date fair value per option granted during the years ended December 31, 2018 and 2017 was $1.61 and $1.58, respectively. The aggregate intrinsic value of stock options exercised during the years ended December 31, 2018 and 2017 was approximately $0 and $107, respectively.

 

In connection with the restricted stock units granted to non-employee directors, the Company accrues compensation expense based on the estimated number of shares expected to be issued, utilizing the most current information available to the Company at the date of the consolidated financial statements. The Company estimates the fair value of the restricted stock unit awards based upon the market price of the underlying common stock on the date of grant.

 

As of December 31, 2018, there was approximately $703 of total unrecognized compensation cost related to non-vested share-based compensation arrangements, including stock options and restricted stock units. This compensation cost is expected to be recognized approximately over four years.